These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

839 related items for PubMed ID: 17553051

  • 1. A multicentre, randomized, controlled study of the efficacy, safety and cost-effectiveness of a combination therapy with amorolfine nail lacquer and oral terbinafine compared with oral terbinafine alone for the treatment of onychomycosis with matrix involvement.
    Baran R, Sigurgeirsson B, de Berker D, Kaufmann R, Lecha M, Faergemann J, Kerrouche N, Sidou F.
    Br J Dermatol; 2007 Jul; 157(1):149-57. PubMed ID: 17553051
    [Abstract] [Full Text] [Related]

  • 2. Topical amorolfine for 15 months combined with 12 weeks of oral terbinafine, a cost-effective treatment for onychomycosis.
    Baran R.
    Br J Dermatol; 2001 Oct; 145 Suppl 60():15-9. PubMed ID: 11777260
    [Abstract] [Full Text] [Related]

  • 3. Combination of oral terbinafine and topical ciclopirox compared to oral terbinafine for the treatment of onychomycosis.
    Avner S, Nir N, Henri T.
    J Dermatolog Treat; 2005 Oct; 16(5-6):327-30. PubMed ID: 16428154
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of topical resin lacquer, amorolfine and oral terbinafine for treating toenail onychomycosis: a prospective, randomized, controlled, investigator-blinded, parallel-group clinical trial.
    Auvinen T, Tiihonen R, Soini M, Wangel M, Sipponen A, Jokinen JJ.
    Br J Dermatol; 2015 Oct; 173(4):940-8. PubMed ID: 26036329
    [Abstract] [Full Text] [Related]

  • 5. Amorolfine and itraconazole combination for severe toenail onychomycosis; results of an open randomized trial in Spain.
    Lecha M.
    Br J Dermatol; 2001 Oct; 145 Suppl 60():21-6. PubMed ID: 11777261
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Pulse itraconazole vs. continuous terbinafine for the treatment of dermatophyte toenail onychomycosis in patients with diabetes mellitus.
    Gupta AK, Gover MD, Lynde CW.
    J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1188-93. PubMed ID: 17062029
    [Abstract] [Full Text] [Related]

  • 10. Ciclopirox topical solution, 8% combined with oral terbinafine to treat onychomycosis: a randomized, evaluator-blinded study.
    Gupta AK, Onychomycosis Combination Therapy Study Group.
    J Drugs Dermatol; 2005 Nov; 4(4):481-5. PubMed ID: 16004022
    [Abstract] [Full Text] [Related]

  • 11. Treatment costs of three nail lacquers used in onychomycosis.
    Marty JP, Lambert J, Jäckel A, Adjadj L.
    J Dermatolog Treat; 2005 Nov; 16(5-6):299-307. PubMed ID: 16428149
    [Abstract] [Full Text] [Related]

  • 12. Economic analysis of oral and topical therapies for onychomycosis of the toenails and fingernails.
    Casciano J, Amaya K, Doyle J, Arikian S, Shear N, Haspel M, Kahler K.
    Manag Care; 2003 Mar; 12(3):47-54. PubMed ID: 12685377
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Pulse versus continuous terbinafine for onychomycosis: a randomized, double-blind, controlled trial.
    Warshaw EM, Fett DD, Bloomfield HE, Grill JP, Nelson DB, Quintero V, Carver SM, Zielke GR, Lederle FA.
    J Am Acad Dermatol; 2005 Oct; 53(4):578-84. PubMed ID: 16198776
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Topical antifungal drugs for the treatment of onychomycosis: an overview of current strategies for monotherapy and combination therapy.
    Baran R, Kaoukhov A.
    J Eur Acad Dermatol Venereol; 2005 Jan; 19(1):21-9. PubMed ID: 15649187
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.